找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Planning and Analyzing Clinical Trials with Composite Endpoints; Geraldine Rauch,Svenja Schüler,Meinhard Kieser Book 2017 Springer Interna

[復(fù)制鏈接]
查看: 18821|回復(fù): 35
樓主
發(fā)表于 2025-3-21 17:18:38 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints
編輯Geraldine Rauch,Svenja Schüler,Meinhard Kieser
視頻videohttp://file.papertrans.cn/749/748363/748363.mp4
概述Discusses methods for planning and evaluating clinical trials with a composite primary endpoint.Offers software codes for the implementation of methods.Summarizes current medical and methodology guide
叢書(shū)名稱Springer Series in Pharmaceutical Statistics
圖書(shū)封面Titlebook: Planning and Analyzing Clinical Trials with Composite Endpoints;  Geraldine Rauch,Svenja Schüler,Meinhard Kieser Book 2017 Springer Interna
描述.This book addresses the most important aspects of how to plan and evaluate clinical trials with a composite primary endpoint to guarantee a clinically meaningful and valid interpretation of the results. Composite endpoints are often used as primary efficacy variables for clinical trials, particularly in the fields of oncology and cardiology. These endpoints combine several variables of interest within a single composite measure, and as a result, all variables that are of major clinical relevance can be considered in the primary analysis without the need to adjust for multiplicity. Moreover, composite endpoints are intended to increase the size of the expected effects thus making clinical trials more powerful. . .The book offers practical advice for statisticians and medical experts involved in the planning and analysis of clinical trials. For readers who are mainly interested in the application of the methods, all the approaches are illustrated with real-world clinical trial examples, and the software codes required for fast and easy implementation are provided. The book also discusses all the methods in the context of relevant guidelines related to the topic. To benefit most from
出版日期Book 2017
關(guān)鍵詞62L05, 62P10; composite endpoints; clinical trials; sample size calculation; sequential designs; multiple
版次1
doihttps://doi.org/10.1007/978-3-319-73770-6
isbn_softcover978-3-030-08855-2
isbn_ebook978-3-319-73770-6Series ISSN 2366-8695 Series E-ISSN 2366-8709
issn_series 2366-8695
copyrightSpringer International Publishing AG, part of Springer Nature 2017
The information of publication is updating

書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints影響因子(影響力)




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints影響因子(影響力)學(xué)科排名




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints被引頻次




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints被引頻次學(xué)科排名




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints年度引用




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints年度引用學(xué)科排名




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints讀者反饋




書(shū)目名稱Planning and Analyzing Clinical Trials with Composite Endpoints讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:14:21 | 只看該作者
第148363主題貼--第2樓 (沙發(fā))
板凳
發(fā)表于 2025-3-22 01:29:39 | 只看該作者
板凳
地板
發(fā)表于 2025-3-22 05:13:54 | 只看該作者
第4樓
5#
發(fā)表于 2025-3-22 11:53:56 | 只看該作者
5樓
6#
發(fā)表于 2025-3-22 14:55:41 | 只看該作者
6樓
7#
發(fā)表于 2025-3-22 17:20:39 | 只看該作者
7樓
8#
發(fā)表于 2025-3-22 21:30:39 | 只看該作者
8樓
9#
發(fā)表于 2025-3-23 02:25:51 | 只看該作者
9樓
10#
發(fā)表于 2025-3-23 06:39:39 | 只看該作者
10樓
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-17 13:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
武乡县| 日土县| 定襄县| 博爱县| 抚顺县| 大埔县| 灵台县| 南雄市| 广元市| 沙田区| 普兰店市| 防城港市| 武功县| 永吉县| 丰镇市| 海安县| 枝江市| 定南县| 蓬莱市| 肥乡县| 武清区| 盘山县| 循化| 水城县| 屏山县| 辛集市| 申扎县| 济阳县| 军事| 内江市| 施甸县| 建德市| 南投县| 花垣县| 克山县| 荣成市| 嘉黎县| 中卫市| 甘南县| 辽阳县| 海淀区|